Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 21 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Vaios, Vasilios [Clear All Filters]
(2020).
Accuracy of a Newly-Introduced Oscillometric Device for the Estimation of Arterial Stiffness Indices in Patients on Peritoneal Dialysis: A Preliminary Validation Study..
Adv Perit Dial. 34(2018), 24-31.
(2018). Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab..
Case Rep Nephrol. 2019, 3614980.
(2019). Assessment and Management of Hypertension among Patients on Peritoneal Dialysis..
Clin J Am Soc Nephrol. 14(2), 297-305.
(2019). Blood pressure and target-organ damage in hemodialysis: but which blood pressure?.
J Hypertens. 35(12), 2552-2553.
(2017). Blood pressure targets in patients with chronic kidney disease: A critical evaluation of clinical-trial evidence and guideline recommendations..
J Clin Hypertens (Greenwich). 22(5), 924-928.
(2020). Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis..
J Clin Densitom. 20(4), 490-497.
(2017). Clinic and Home Blood Pressure Monitoring for the Detection of Ambulatory Hypertension Among Patients on Peritoneal Dialysis..
Hypertension. 74(4), 998-1004.
(2019).
(2023).
(2017).
Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology..
Diagnostics (Basel). 12(12),
(2022). Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report..
BMC Nephrol. 19(1), 293.
(2018).
(2022). Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence..
Curr Vasc Pharmacol. 15(6), 599-606.
(2017). Prevalence and control of hypertension among patients on haemodialysis..
Eur J Clin Invest. 50(10), e13292.
(2020). Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis..
Am J Hypertens. 35(11), 918-922.
(2022). Prevalence, recurrence and seasonal variation of hyperkalemia among patients on hemodialysis..
Int Urol Nephrol. 54(9), 2327-2334.
(2022).
(2020). Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?.
Expert Opin Pharmacother.
(2023). Therapeutic Advances in Diabetic Kidney Disease..
Int J Mol Sci. 24(3),
(2023). Thrombophilia in hemodialysis patients: Transfer to peritoneal dialysis is life saving..
Semin Dial. 33(4), 338-342.
(2020).